We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.4B
2
NVDA icon
NVIDIA
NVDA
+$388M
3
MSFT icon
Microsoft
MSFT
+$182M
4
AMZN icon
Amazon
AMZN
+$177M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$163M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$213M
2
AVGO icon
Broadcom
AVGO
+$103M
3
UNP icon
Union Pacific
UNP
+$100M
4
ETHA
iShares Ethereum Trust ETF
ETHA
+$89.9M
5
MRVL icon
Marvell Technology
MRVL
+$89.4M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GERN icon
1926
Geron
GERN
$962M
$20.2K ﹤0.01%
15,324
-748,187
-98% -$939K
SOUL.RT
1927
Soulpower Acquisition Corp Rights
SOUL.RT
$19.5K ﹤0.01%
111,305
-141,328
-56% -$27.8K
SDHIR
1928
Siddhi Acquisition Corp Right
SDHIR
$19.3K ﹤0.01%
89,558
-61,053
-41% -$15.9K
PMCB icon
1929
PharmaCyte Biotech
PMCB
$6.29M
$19K ﹤0.01%
26,178
-22
-0.1% -$20
TAVIR
1930
Tavia Acquisition Corp Right
TAVIR
$18.4K ﹤0.01%
80,000
-52,632
-40% -$12.3K
DRDBW
1931
Roman DBDR Acquisition Corp II Warrants
DRDBW
$2.21M
$18.3K ﹤0.01%
30,000
-2,500
-8% -$1.64K
REFR icon
1932
Research Frontiers
REFR
$17M
$18.1K ﹤0.01%
13,836
+300
+2% +$507
INACR
1933
Indigo Acquisition Corp Right
INACR
$17.4K ﹤0.01%
120,000
+20,000
+20% +$3.49K
MYPS icon
1934
PLAYSTUDIOS Inc
MYPS
$92.8M
$16.3K ﹤0.01%
25,000
– –
ANTX icon
1935
AN2 Therapeutics
ANTX
$213M
$16.3K ﹤0.01%
14,281
– –
AIFC
1936
AI Financial Corp
AIFC
$61.4M
$16.3K ﹤0.01%
14,796
-1,787
-11% -$3.44K
EVAC.WS
1937
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
$15.7K ﹤0.01%
45,000
+5,000
+13% +$1.78K
LEDS icon
1938
SemiLEDS
LEDS
$18M
$15.4K ﹤0.01%
10,277
-99
-1% -$223
LXRX icon
1939
Lexicon Pharmaceuticals
LXRX
$1.04B
$15.1K ﹤0.01%
13,108
-812,525
-98% -$1.12M
VTGN icon
1940
VistaGen Therapeutics
VTGN
$13.4M
$14.4K ﹤0.01%
21,736
+10,853
+100% +$39.2K
EMISR
1941
Emmis Acquisition Corp Rights
EMISR
$13.9K ﹤0.01%
+86,786
New +$13.8K
VACHW
1942
DELISTED
Voyager Acquisition Corp Warrants
VACHW
$13.8K ﹤0.01%
66,444
-21,582
-25% -$4.88K
LPAAW
1943
Launch One Acquisition Corp Warrant
LPAAW
$1.73M
$13.7K ﹤0.01%
54,830
-11,066
-17% -$2.65K
SSEAR
1944
Starry Sea Acquisition Corp Rights
SSEAR
$13.3K ﹤0.01%
+61,793
New +$16K
CHPGR
1945
ChampionsGate Acquisition Corp Rights
CHPGR
$12.8K ﹤0.01%
76,100
-29,953
-28% -$4.96K
NMPAR
1946
NMP Acquisition Corp Right
NMPAR
$12.7K ﹤0.01%
63,460
-940
-1% -$219
CCIIW
1947
Cohen Circle Acquisition Corp II Warrant
CCIIW
$5.2M
$12.6K ﹤0.01%
18,000
-2,000
-10% -$1.55K
PELIR
1948
DELISTED
Pelican Acquisition Corp Right
PELIR
$12K ﹤0.01%
52,264
+2,264
+5% +$603
POLEW
1949
Andretti Acquisition Corp II Warrant
POLEW
$1.84M
$11.6K ﹤0.01%
40,140
-23,660
-37% -$6.9K
QUMSR
1950
Quantumsphere Acquisition Corp Rights
QUMSR
$11.5K ﹤0.01%
+54,599
New +$14.2K
76 77
78
79 80

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.